Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Medicenna Therapeutics Corp. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2030 | $82.79M | $82.79M - $82.79M | $0.00 | $0.32 | 1 |
| Mar 2029 | $54.36M | $54.36M - $54.36M | $0.00 | $0.13 | 3 |
| Mar 2028 | $15.56M | $15.56M - $15.56M | $0.00 | -$0.16 | 3 |
| Mar 2027 | $895.8K | $895.7K - $895.9K | $0.00 | -$0.393 | 3 |
| Mar 2026 | $218.8K | $218.8K - $218.8K | $0.00 | -$0.238 | 2 |
| Mar 2025 | $145.8K | $145.7K - $145.9K | $0.00 | -$0.213 | 2 |